These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Abacavir and warfarin modulate allosterically kinetics of NO dissociation from ferrous nitrosylated human serum heme-albumin.
    Author: Ascenzi P, Imperi F, Coletta M, Fasano M.
    Journal: Biochem Biophys Res Commun; 2008 May 02; 369(2):686-91. PubMed ID: 18307975.
    Abstract:
    Human serum albumin (HSA) participates to heme scavenging, in turn HSA-heme binds gaseous diatomic ligands at the heme-Fe-atom. Here, the effect of abacavir and warfarin on denitrosylation kinetics of HSA-heme-Fe(II)-NO (i.e., k(off)) is reported. In the absence of drugs, the value of k(off) is (1.3+/-0.2) x 10(-4)s(-1). Abacavir and warfarin facilitate NO dissociation from HSA-heme-Fe(II)-NO, the k(off) value increases to (8.6+/-0.9) x 10(-4)s(-1). From the dependence of k(off) on the drug concentration, values of the dissociation equilibrium constant for the abacavir and warfarin binding to HSA-heme-Fe(II)-NO (i.e., K=(1.2+/-0.2) x 10(-3)M and (6.2+/-0.7) x 10(-5)M, respectively) were determined. The increase of k(off) values reflects the stabilization of the basic form of HSA-heme-Fe by ligands (e.g., abacavir and warfarin) that bind to Sudlow's site I. This event parallels the stabilization of the six-coordinate derivative of the HSA-heme-Fe(II)-NO atom. Present data highlight the allosteric modulation of HSA-heme-Fe(II) reactivity by heterotropic effectors.
    [Abstract] [Full Text] [Related] [New Search]